BMP-7-loaded PGLA microspheres as a new delivery system for the cultivation of human chondrocytes in a collagen type I gel: The common nude mouse model

International Journal of Artificial Organs

Volumn 33, Issue 1, 2010, Pages 45-53

  Gavenis, Karsten ^a   Schneider, Ulrich ^b   Groll, Jürgen ^c   Schmidt Rohlfing, Bernhard ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b Arthro Nova Clinic   (Germany)

^c Deutsches Wollforschungsinstitut   (Germany)

Author keywords

Articular chondrocytes; BMP 7; Collagen gel; Nude mouse system; PGLA microspheres

Indexed keywords

BODY FLUIDS; CARTILAGE; COLLAGEN; GENE EXPRESSION; GLYCOPROTEINS; MAMMALS; TISSUE ENGINEERING;

ARTICULAR CHONDROCYTES; BONE MORPHOGENIC PROTEIN; BONE MORPHOGENIC PROTEIN 7; COLLAGEN GELS; COLLAGEN TYPE I; IN-VIVO; NUDE MICE; NUDE MOUSE SYSTEM; PGLA MICROSPHERE; TYPE II;

MICROSPHERES;

AGGRECAN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; MICROSPHERE; POLYLACTIDE; RECOMBINANT OSTEOGENIC PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL STRUCTURE; CELL TRANSFER; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION; EXTRACELLULAR MATRIX; GEL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYALINE CARTILAGE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUDE MOUSE; OSTEOARTHRITIS; PROTEIN ANALYSIS; PROTEIN CONTENT; SPHEROID CELL; TISSUE ENGINEERING; TISSUE REPAIR;

EID: 77649264481     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139881003300107     Document Type: Article

References (34)

1. Beiser IH, Kanat IO. Subchondral bone drilling: A treatment for cartilage defects. J Foot Surg 1990; 29: 595-601.
2. O'Driscoll SW. The healing and regeneration of articular cartilage. J Bone Joint Surg (Am) 1998; 80: 1795-1812.
3. Gilbert JE. Current treatment options for the restoration of articular cartilage. Am J Knee Surg 1998; 11: 42-6.
4. Gavénis K, Schmidt-Rohlfing B, Mueller-Rath R, Andereya S, Schneider U. In vitro comparison of six different matrix systems for the cultivation of human chondrocytes. In Vitro Cell Dev Biol Anim 2006; 42: 159-67.
5. Schuman L, Buma P, Versleyen D, et al. Chondrocyte behaviour within different types of collagen gel in vitro. Biomaterials 1995; 16: 809-14.
6. Uchio Y, Ochi M, Matsusaki M, Kurioka H, Katsube K, Ochi M. Human chondrocyte proliferation and matrix synthesis cultured in Atelocollagen gel. J Biomed Mater Res 2000; 50: 138-43.
7. Andereya S, Maus U, Gavenis K, et al. First clinical experiences with a novel 3D-collagen gel (CaReS) for the treatment of focal cartilage defects in the knee. Z Orthop Ihre Grenzgeb 2006; 144: 272-80.
8. Vacanti CA, Langer R, Schloo B, Vacanti JP. Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation. Plast Reconstr Surg 1991; 88: 753-9.
9. Chen G, Sato T, Ushida T, et al. The use of a novel PLGA fiber/collagen composite web as a scaffold for engineering of articular cartilage tissue with adjustable thickness. J Biomed Mater Res A 2003; 15: 1170-80.
10. Kang S-W, Jeon O, Kim B-S. Poly(lactic-co-glycolic acid) microspheres as an injectable scaffold for cartilage tissue engineering. Tissue Eng 2005; 11: 438-47.
11. Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 1997; 28: 5-24.
12. Freitas S, Merkle HP, Gander B. Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Control Release 2005; 102: 313-32.
13. Chubinskaya S, Kuettner KE. Regulation of osteogenic proteins by chondrocytes. Int J Biochem Cell Biol 2003; 35: 1323-40.
14. Flechtenmacher J, Huch K, Thonar EJ, et al. Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes. Arthritis Rheum 1996; 39: 1896-904.
15. Nishida Y, Knudson CB, Eger W, Kuettner KE, Knudson W. Osteogenic protein 1 stimulates cell-associated matrix assembly by normal human articular chondrocytes: up-regulation of hyaluronan synthase, CD44, and aggrecan. Arthritis Rheum 2000; 43: 206-14.
16. Loeser RF, Pacione CA, Chubinskaya S. The combination of insulin-like growth factor 1 and osteogenic protein 1 promotes increased survival of and matrix synthesis by normal and osteoarthritic human articular chondrocytes. Arthritis Rheum 2003; 48: 2188-96.
17. Fan Z, Chubinskaya S, Rueger DC, Bau B, Haag J, Aigner T. Regulation of anabolic and catabolic gene expression in normal and osteoarthritic adult human articular chondrocytes by osteogenic protein-1. Clin Exp Rheumatol 2004; 22: 103-6.
18. Nishida Y, Knudson CB, Knudson W. Osteogenic protein-1 inhibits matrix depletion in a hyaluronan hexasaccharide-induced model of osteoarthritis. Osteoarthr Cartil 2004; 12: 374-82.
19. Cook SD, Patron LP, Salkeld SL, Rueger DC. Repair of articular cartilage defects with osteogenic protein-1 (BMP-7) in dogs. J Bone Joint Surg (Am) 2003; 85-A (Suppl 3): 116-23.
20. Gavenis K, Klee D, Pereira-Paz RM, et al. BMP-7 loaded microspheres as a new delivery system for the cultivation of human chondrocytes in a collagen type-I gel. J Biomed Mater Res B Appl Biomater 2007; 82: 275-83.
21. Athanasiou KA, Niederauer GG, Agrawal CM. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 1996; 17: 93-102.
22. Gilding DK. Biodegradable polymers. In: Williams, DF, ed. Biocompatibility of clinical implant materials. Boca Raton, FL: CRC Press, 1981; 209-32.
23. Kim BS, Baez CE, Atala A. Biomaterials for tissue engineering. World J Urol 2000; 18: 2-9.
24. Lu L, Zhu X, Valenzuela RG, Currier BL, Yaszemski MJ. Biodegradable polymer scaffolds for cartilage tissue engineering. Clin Orthop Relat Res 2001; 391: 251-70.
25. Huch K, Wilbrink B, Flechtenmacher J, et al. Effects of recombinant human osteogenic protein 1 on the production of proteoglycan, prostaglandin E2, and interleukin-1 receptor antagonist by human articular chondrocytes cultured in the presence of interleukin-1beta. Arthritis Rheum 1997; 40: 2157-61.
26. Stöve J, Schneider-Wald B, Scharf HP, Schwarz ML. Bone morphogenetic protein 7 (bmp-7) stimulates proteoglycan synthesis in human osteoarthritic chondrocytes in vitro. Biomed Pharmacother 2006; 60: 639-43.
27. Doré S, Pelletier JP, DiBattista JA, Tardif G, Brazeau P, Martel-Pelletier J. Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor 1 binding sites but are unresponsive to its stimulation: possible role of IGF-1-binding proteins. Arthritis Rheum 1994; 37: 253-63.
28. Chubinskaya S, Hakimiyan A, Pacione C, et al. Synergistic effect of IGF-1 and OP-1 on matrix formation by normal and OA chondrocytes cultured in alginate beads. Osteoarthr Cartil 2007; 15: 421-30.
29. Chubinskaya S, Kawakami M, Rappoport L, Matsumoto T, Migita N, Rueger DC. Anti-catabolic effect of OP-1 in chronically compressed intervertebral discs. J Orthop Res 2007; 25: 517-30.
30. Cook SD. Preclinical and clinical evaluation of osteogenic protein-1 (BMP-7) in bony sites. Orthopedics 1999; 22: 669-71.
31. Friedlaender GE, Perry CR, Cole JD, et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg (Am) 2001; 83-A (Suppl 1): 151-8.
32. Munirah S, Kim SH, Ruszymah BHI, Khang G. The use of fibrin and poly(lactic-co-glycolic acid) hybrid scaffold for articular cartilage tissue engineering: an in vivo analysis. Eur Cell Mater 2008; 15: 41-52.
33. Aurich M, Anders J, Trommer T, et al. Histological and cell biological characterization of dissected cartilage fragments in human osteochondritis dissecans of the femoral condyle. Arch Orthop Trauma Surg 2006; 126: 606-14.
34. Kaps C, Bramlage C, Smolian H, et al. Bone morphogenetic proteins promote cartilage differentiation and protect engineered artificial cartilage from fibroblast invasion and destruction. Arthritis Rheum 2002; 46: 149-62.